GSK1904529A

 化学構造式
1089283-49-7
CAS番号.
1089283-49-7
化学名:
别名:
英語名:
GSK1904529A
英語别名:
CS-29;GSK 4529;GSK1904529A;GSK1904529A, >=98%;GSK1904529A (GSK-4529;IGF-IR, IGF-IIR inhibitor;IGF-1R inhibitor GS1904529A;GSK1904529A ISO 9001:2015 REACH;GSK1904529A;GSK-1904529A;GSK 1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor
CBNumber:
CB92501005
化学式:
C44H47F2N9O5S
分子量:
851.96
MOL File:
1089283-49-7.mol

GSK1904529A 物理性質

比重(密度) :
1.39
貯蔵温度 :
Store at -20°C
溶解性:
≥42.6 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
外見 :
solid
酸解離定数(Pka):
11.12±0.70(Predicted)

安全性情報

GSK1904529A 価格 もっと(2)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) SML3675 GSK1904529A ≥98% (HPLC)
≥98% (HPLC)
1089283-49-7 5mg ¥21200 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) SML3675 GSK1904529A ≥98% (HPLC)
≥98% (HPLC)
1089283-49-7 25mg ¥85300 2024-03-01 購入

GSK1904529A 化学特性,用途語,生産方法

使用

A selective inhibitor of IGF-1R and IR with IC50s of 27 nM and 25 nM, respectively.

GSK1904529A 上流と下流の製品情報

原材料

準備製品


GSK1904529A 生産企業

Global( 108)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806
sales@capotchem.com China 29797 60
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49390 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 9320 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 29220 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
TargetMol Chemicals Inc.
+1-781-999-5354
support@targetmol.com United States 19973 58

  スペクトルデータ(1HNMR)


1089283-49-7()キーワード:


  • 1089283-49-7
  • GSK 4529
  • GSK1904529A
  • GSK1904529A : IGF-IR, IGF-IIR inhibitor
  • N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide
  • N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
  • N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A
  • GSK1904529A, >=98%
  • IGF-IR, IGF-IIR inhibitor
  • N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]
  • CS-29
  • GSK1904529A;GSK-1904529A;GSK 1904529A
  • Benzamide, N-(2,6-difluorophenyl)-5-[3-[2-[[5-ethyl-2-methoxy-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-methoxy-
  • GSK1904529A ISO 9001:2015 REACH
  • GSK1904529A (GSK-4529
  • N-(2,6-Difluorophenyl)-5-(3-(2-((5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide
  • IGF-1R inhibitor GS1904529A
Copyright 2017 © ChemicalBook. All rights reserved